Collaborations to Enhance Drug Development and Regulatory Science - Clinical Trials Optional

The summary for the Collaborations to Enhance Drug Development and Regulatory Science - Clinical Trials Optional grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Food and Drug Administration, which is the U.S. government agency offering this grant.

Collaborations to Enhance Drug Development and Regulatory Science - Clinical Trials Optional: This Notice of Funding Opportunity (NOFO) invites applications for a cooperative agreement to support, manage and facilitate Public-Private Partnerships and Collaborative activities as part of the Critical Path Initiative and to support regulatory science efforts. FDA and grantees will work together to develop innovative, collaborative projects in research, education, and outreach. These projects can help foster drug product innovation to 1) support efforts to accelerate drug product development; 2) support approaches to advanced manufacturing; 3) facilitate translation of basic science discoveries into therapeutics; and 4) facilitate approaches to enhance the safety, efficacy, quality, and performance of drug products. Projects are identified by FDA. Multiple awards may be funded under this NOFO and are directly dependent on drug development priorities and subject to the availability of funding.

Federal Grant Title:	Collaborations to Enhance Drug Development and Regulatory Science - Clinical Trials Optional
Federal Agency Name:	Food and Drug Administration (HHS-FDA)
Grant Categories:	Agriculture Consumer Protection Food and Nutrition
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-FD-24-029
Type of Funding:	Cooperative Agreement
CFDA Numbers:	93.103
CFDA Descriptions:	Information not provided
Current Application Deadline:	March 4th, 2024
Original Application Deadline:	March 4th, 2024
Posted Date:	January 4th, 2024
Creation Date:	January 4th, 2024
Archive Date:	April 3rd, 2024
Total Program Funding:	$5,000,000
Maximum Federal Grant Award:	$5,000,000
Minimum Federal Grant Award:
Expected Number of Awards:	6
Cost Sharing or Matching:	No
Last Updated:	January 4th, 2024

Applicants Eligible for this Grant: Private institutions of higher education - Others (see text field entitled "Additional Information on Eligibility" for clarification.)
Additional Information on Eligibility: (1) The entity is- (A) an institution of higher education (as such term is defined in section 1001 of title 20) or a consortium of such institutions; or (B) an organization described in section 501(c)(3) of title 26 and exempt from tax under section 501(a) of such title. (2) The entity has experienced personnel and clinical and other technical expertise in the biomedical sciences, which may include graduate training programs in areas relevant to priorities of the Critical Path Initiative. (3) The entity demonstrates they are capable of- (A) developing and critically evaluating tools, methods, and processes- (i) to increase efficiency, predictability, and productivity or medical product development; and (ii)to more accurately identify the benefits and risks of new and existing medical products (B) establishing partnerships and collaborations with health care practitioners and other providers of health care goods or services; pharmacists; pharmacy benefit managers and purchasers; health maintenance organizations and other managed health care organizations; health care insurers; government agencies; patients and consumers; manufacturers of prescription drugs, biological products, diagnostic technologies, and devices; and academic scientists; and (C) securing funding for the projects of a Critical Path Public-Private Partnership from Federal and nonfederal governmental sources, foundations, and private individuals.
Grant Announcement Contact: Terrin Brown
Grantor
Phone 2404027610
[email protected]
Similar Government Grants: • Clinical Trials Addressing Unmet Needs of Rare Neurodegenerative Diseases (R01) Clinical T...; • Single Source Cooperative Agreement to Support HPAI H5N1 Research at Cornell University (U...; • Animal and Veterinary Innovation Centers (U18); • Cooperative Agreement to Support the Illinois Institute of Technology's Institute for Food...; • Minor Use Minor Species Development of Drugs (R01); • Support for Small Scientific Conference Grant Program; • Cooperative Agreement to Support the World Health Organization (WHO) International Program...; • Clinical Studies of Safety and Effectiveness of Orphan Products
More Grants from the Food and Drug Administration: • Clinical Trials Addressing Unmet Needs of Rare Neurodegenerative Diseases (R01) Clinical T...; • Single Source Cooperative Agreement to Support HPAI H5N1 Research at Cornell University (U...; • Animal and Veterinary Innovation Centers (U18)